Guangdong Cellwise Microelectronics Co Ltd
SSE:688325
Guangdong Cellwise Microelectronics Co Ltd
SSE:688325
Price:
117.26
CNY
-1.18%
Market Closed
Market Cap:
¥10.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Guangdong Cellwise Microelectronics Co Ltd
SSE:688325
|
CN |
|
Themis Medicare Ltd
NSE:THEMISMED
|
IN |
|
Maskapai Reasuransi Indonesia Tbk PT
IDX:MREI
|
ID |
|
Rikei Corp
TSE:8226
|
JP |
|
Huishang Bank Corp Ltd
HKEX:3698
|
CN |
|
C
|
CPI Europe AG
VSE:CPI
|
AT |
|
C
|
Conroy Gold and Natural Resources PLC
LSE:CGNR
|
IE |
|
Jiangsu ToLand Alloy Co Ltd
SZSE:300855
|
CN |
|
J
|
Jiangxi Copper Co Ltd
OTC:JIAXF
|
CN |
|
A
|
Asian Granito India Ltd
NSE:ASIANTILES
|
IN |
Income Statement
Earnings Waterfall
Guangdong Cellwise Microelectronics Co Ltd
Guangdong Cellwise Microelectronics Co Ltd
Income Statement
Guangdong Cellwise Microelectronics Co Ltd
Guangdong Cellwise Microelectronics Co Ltd
Currency: CNY
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Revenue |
339
N/A
|
319
-6%
|
284
-11%
|
237
-16%
|
200
-16%
|
175
-12%
|
103
-41%
|
217
+111%
|
393
+81%
|
420
+7%
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
(129)
|
(124)
|
(114)
|
(99)
|
(92)
|
(76)
|
(50)
|
(103)
|
(191)
|
(200)
|
|
| Gross Profit |
210
N/A
|
195
-7%
|
171
-12%
|
138
-19%
|
108
-22%
|
99
-8%
|
53
-47%
|
114
+117%
|
202
+77%
|
220
+9%
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(118)
|
(113)
|
(118)
|
(115)
|
(103)
|
(114)
|
(38)
|
(78)
|
(163)
|
(173)
|
|
| Selling, General & Administrative |
(52)
|
(48)
|
(49)
|
(46)
|
(42)
|
(44)
|
(13)
|
(25)
|
(53)
|
(53)
|
|
| Research & Development |
(64)
|
(65)
|
(66)
|
(67)
|
(61)
|
(70)
|
(27)
|
(55)
|
(105)
|
(121)
|
|
| Depreciation & Amortization |
(5)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(10)
|
0
|
|
| Other Operating Expenses |
1
|
1
|
(2)
|
(2)
|
6
|
1
|
2
|
3
|
5
|
2
|
|
| Operating Income |
92
N/A
|
82
-11%
|
53
-35%
|
23
-56%
|
5
-78%
|
(15)
N/A
|
14
N/A
|
36
+153%
|
39
+8%
|
47
+22%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
(1)
|
(1)
|
4
|
11
|
30
|
39
|
10
|
19
|
41
|
40
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
|
| Total Other Income |
2
|
4
|
17
|
18
|
16
|
13
|
0
|
(1)
|
(1)
|
(2)
|
|
| Pre-Tax Income |
92
N/A
|
84
-8%
|
75
-12%
|
52
-30%
|
52
-2%
|
38
-27%
|
24
-36%
|
55
+127%
|
77
+42%
|
85
+10%
|
|
| Net Income | |||||||||||
| Tax Provision |
(2)
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
1
|
2
|
|
| Income from Continuing Operations |
89
|
85
|
75
|
53
|
52
|
38
|
23
|
53
|
79
|
87
|
|
| Net Income (Common) |
89
N/A
|
85
-5%
|
75
-12%
|
53
-30%
|
52
-2%
|
38
-26%
|
23
-40%
|
53
+130%
|
79
+50%
|
87
+10%
|
|
| EPS (Diluted) |
1.12
N/A
|
1.06
-5%
|
0.94
-11%
|
0.66
-30%
|
0.65
-2%
|
0.48
-26%
|
0.28
-42%
|
0.65
+132%
|
0.92
+42%
|
1.01
+10%
|
|
Switch to:
Switch to:
See Also
Discover More
